Akèy › Sakom Patisyon Sou Alveolè
Etid klinik pou Sakom Patisyon Sou Alveolè ap rekrite nan Etazini
5 etid pou Sakom Patisyon Sou Alveolè ap rekrite patisipan nan sit atravè Etazini.
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT05333458A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Ap rekriteFaz 1
Laj 18 a 120 · Tout sèks · Mizajou Sep 22, 2026 · NCT06066138Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Ap rekriteFaz 1/2
6 Months – 25 Years · Tout sèks · Mizajou Jun 30, 2026 · NCT06625190A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT04332874Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Feb 25, 2026 · NCT03016819Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.